Additionally, our study revealed that DNMT1 and DNMT3A mediate the hypermethylation of the CBX7 promoter, leading to its frequent silencing in glioblastoma cell lines and primary tumor tissues. The gene discussed is DNMT3A; the disease is neoplasm.